The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases

Area of Science:

• Immunology
• Molecular Biology
• Gastroenterology

Background:

• The IL-1 superfamily member, Il1rl1 (ST2), interacts with IL-33.
• ST2 has two splice variants: soluble (sST2) acting as a decoy receptor and membrane-bound ST2 activating signaling pathways.
• sST2 is elevated in inflammatory bowel disease, transplant rejection, cancers, infections, and other conditions.

Purpose of the Study:

• To review the role of ST2/IL-33 signaling in inflammatory disease states.
• To explore potential therapeutic interventions targeting the ST2/IL-33 pathway.

Main Methods:

• Literature review focusing on ST2/IL-33 signaling mechanisms.
• Analysis of sST2 levels in various human diseases.
• Examination of ST2 expression in immune cells during inflammation.

Main Results:

• sST2 levels correlate with active inflammation in conditions like IBD and transplant rejection.
• sST2 is secreted by pro-inflammatory T cells, while protective ST2-expressing Tregs decrease during gut inflammation.
• ST2/IL-33 signaling influences mast cells, Th2 cells, Tregs, and innate lymphoid cells.

Conclusions:

• ST2/IL-33 signaling plays a significant role in intestinal inflammation and other inflammatory diseases.
• Modulating ST2/IL-33 signaling presents a potential therapeutic strategy for inflammatory conditions.